JNK Cancer Research Results

JNK, c-Jun N-terminal kinase (JNK): Click to Expand ⟱
Source:
Type:
JNK acts synergistically with NF-κB, JAK/STAT, and other signaling molecules to exert a survival function. Janus signaling promotes cancer cell survival.
JNK, or c-Jun N-terminal kinase, is a member of the mitogen-activated protein kinase (MAPK) family. It plays a crucial role in various cellular processes, including cell proliferation, differentiation, and apoptosis (programmed cell death). JNK is activated in response to various stress signals, such as UV radiation, oxidative stress, and inflammatory cytokines.
JNK activation can promote apoptosis in cancer cells, acting as a tumor suppressor. However, in other contexts, it can promote cell survival and proliferation, contributing to tumor progression.

JNK is often unregulated in cancers, leading to increased cancer cell proliferation, survival, and resistance to apoptosis. This activation is typically associated with poor prognosis and aggressive tumor behavior.


Nor, Normal Healthy: Click to Expand ⟱
Normal Healthy

Scientific Papers found: Click to Expand⟱
4561- AgNPs,  VitC,    Cellular Effects Nanosilver on Cancer and Non-cancer Cells: Potential Environmental and Human Health Impacts
- in-vitro, CRC, HCT116 - in-vitro, Nor, HEK293
NRF2↑, TumCCA↑, ROS↑, selectivity↑, *AntiViral↑, *toxicity↝, ETC↓, MMP↓, DNAdam↑, Apoptosis↑, lipid-P↑, other↝, UPR↑, *GRP78/BiP↑, *p‑PERK↑, *cl‑eIF2α↑, *CHOP↑, *JNK↑, Hif1a↓, AntiCan↑, *toxicity↓, eff↑,
3442- ALA,    α‑lipoic acid modulates prostate cancer cell growth and bone cell differentiation
- in-vitro, Pca, 22Rv1 - in-vitro, Pca, C4-2B - in-vitro, Nor, 3T3
tumCV↓, TumCMig↓, TumCI↓, ROS↑, Hif1a↑, JNK↑, Casp↑, TumCCA↑, Apoptosis↑, selectivity↑,
5880- CAR,    In vitro and in vivo antitumor potential of carvacrol nanoemulsion against human lung adenocarcinoma A549 cells via mitochondrial mediated apoptosis
- vitro+vivo, Lung, A549 - in-vitro, Nor, BEAS-2B - in-vitro, Lung, PC9
Dose↝, mt-ROS↑, p‑JNK↑, BAX↑, Cyt‑c↑, Casp↑, AntiTum↑, ER Stress↑, LDH↑, selectivity↑, Apoptosis↑, DNAdam↑, IRE1↑, XBP-1↑, CHOP↓, p‑eIF2α↓, GRP78/BiP↓, Ca+2↑, MMP↓, Bcl-2↓, Casp3↑, Casp9↑, eff↓, TumW↓, Weight↑, eff↑, eff↑,
6010- CGA,    The Biological Activity Mechanism of Chlorogenic Acid and Its Applications in Food Industry: A Review
- Review, Nor, NA
*antiOx↑, *hepatoP↑, *RenoP↑, AntiTum↑, *glucose↝, *Inflam↓, *neuroP↑, *ROS↓, *Keap1↓, *NRF2↑, *SOD↑, *Catalase↑, *GPx↑, *GSH↑, *MDA↓, *p‑ERK↑, *GRP78/BiP↑, *CHOP↑, *GRP94↑, *Casp3↓, *Casp9↓, *HGF/c-Met↑, *TNF-α↓, *TLR4↓, *MAPK↓, *IL1β↓, *iNOS↓, TCA↓, Glycolysis↓, Bcl-2↓, BAX↑, MAPK↑, JNK↑, CSCs↓, Nanog↓, SOX2↓, CD44↓, OCT4↓, P53↑, P21↑, *SOD1↑, *AGEs↓, *GLUT2↑, *HDL↑, *Fas↓, *HMG-CoA↓, *NF-kB↓, *HO-1↓, *COX2↓, *TLR4↓, *BioAv↑, *BioAv↝, TumCP↓, TumCMig↓, TumCI↓,
1144- CHr,    8-bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK
- in-vitro, HCC, HepG2 - in-vitro, HCC, Bel-7402 - in-vitro, Nor, HL7702
Casp3↑, *ROS∅, ROS↑, JNK↑, *toxicity↓,
1971- GamB,    Gambogic acid triggers vacuolization-associated cell death in cancer cells via disruption of thiol proteostasis
- in-vitro, Nor, MCF10 - in-vitro, BC, MDA-MB-435 - in-vitro, BC, MDA-MB-468 - in-vivo, NA, NA
Paraptosis↑, ER Stress↑, MMP↓, eff↓, selectivity↑, p‑ERK↑, p‑JNK↑, eff↓,
486- MF,    mTOR Activation by PI3K/Akt and ERK Signaling in Short ELF-EMF Exposed Human Keratinocytes
- in-vitro, Nor, HaCaT
*mTOR↑, *PI3K↑, *Akt↑, *p‑ERK↑, *other↑, *p‑JNK↑, *p‑P70S6K↑,
218- MFrot,  MF,    Extremely low frequency magnetic fields inhibit adipogenesis of human mesenchymal stem cells
- in-vitro, Nor, NA
*PPARγ↓, *p‑JNK↑, *Wnt↑, *ALP∅, *COL1∅, *RUNX2∅, *OCN∅, *FABP4↓, *p‑JNK↑, *Diff↓,
1674- PBG,  SDT,  HPT,    Study on the effect of a triple cancer treatment of propolis, thermal cycling-hyperthermia, and low-intensity ultrasound on PANC-1 cells
- in-vitro, PC, PANC1 - in-vitro, Nor, H6c7
tumCV↓, ROS↑, eff↑, Dose∅, selectivity↑, MMP↓, mtDam↑, cl‑PARP↑, p‑ERK↓, p‑JNK↑, p‑p38↑, eff↓, ChemoSen↑,
2005- PLB,    Plumbagin induces apoptosis in lymphoma cells via oxidative stress mediated glutathionylation and inhibition of mitogen-activated protein kinase phosphatases (MKP1/2)
- in-vivo, Nor, EL4 - in-vitro, AML, Jurkat
JNK↑, Cyt‑c↑, FasL↑, BAX↑, ROS↑, *ROS↑, MKP1↓, MKP2↓, selectivity∅, tumCV↑, Cyt‑c↑, Casp3↑, GSH/GSSG↓, ROS↑, mt-ROS↑, *ROS↑, eff↓,
2279- VitK2,    Vitamin K2 Induces Mitochondria-Related Apoptosis in Human Bladder Cancer Cells via ROS and JNK/p38 MAPK Signal Pathways
- in-vitro, Bladder, T24/HTB-9 - in-vitro, Bladder, J82 - in-vitro, Nor, HEK293 - in-vitro, Nor, L02 - in-vivo, NA, NA
MMP↓, Cyt‑c↑, Casp3↑, p‑JNK↑, p‑p38↑, ROS↑, eff↓, tumCV↓, selectivity↑, *toxicity↓, TumVol↓,

Showing Research Papers: 1 to 11 of 11

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 11

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

GSH/GSSG↓, 1,   lipid-P↑, 1,   NRF2↑, 1,   ROS↑, 7,   mt-ROS↑, 2,  

Mitochondria & Bioenergetics

ETC↓, 1,   MMP↓, 5,   mtDam↑, 1,  

Core Metabolism/Glycolysis

Glycolysis↓, 1,   LDH↑, 1,   TCA↓, 1,  

Cell Death

Apoptosis↑, 3,   BAX↑, 3,   Bcl-2↓, 2,   Casp↑, 2,   Casp3↑, 4,   Casp9↑, 1,   Cyt‑c↑, 4,   FasL↑, 1,   JNK↑, 4,   p‑JNK↑, 4,   MAPK↑, 1,   MKP1↓, 1,   MKP2↓, 1,   p‑p38↑, 2,   Paraptosis↑, 1,  

Transcription & Epigenetics

other↝, 1,   tumCV↓, 3,   tumCV↑, 1,  

Protein Folding & ER Stress

CHOP↓, 1,   p‑eIF2α↓, 1,   ER Stress↑, 2,   GRP78/BiP↓, 1,   IRE1↑, 1,   UPR↑, 1,   XBP-1↑, 1,  

DNA Damage & Repair

DNAdam↑, 2,   P53↑, 1,   cl‑PARP↑, 1,  

Cell Cycle & Senescence

P21↑, 1,   TumCCA↑, 2,  

Proliferation, Differentiation & Cell State

CD44↓, 1,   CSCs↓, 1,   p‑ERK↓, 1,   p‑ERK↑, 1,   Nanog↓, 1,   OCT4↓, 1,   SOX2↓, 1,  

Migration

Ca+2↑, 1,   TumCI↓, 2,   TumCMig↓, 2,   TumCP↓, 1,  

Angiogenesis & Vasculature

Hif1a↓, 1,   Hif1a↑, 1,  

Drug Metabolism & Resistance

ChemoSen↑, 1,   Dose↝, 1,   Dose∅, 1,   eff↓, 6,   eff↑, 4,   selectivity↑, 6,   selectivity∅, 1,  

Clinical Biomarkers

LDH↑, 1,  

Functional Outcomes

AntiCan↑, 1,   AntiTum↑, 2,   TumVol↓, 1,   TumW↓, 1,   Weight↑, 1,  
Total Targets: 67

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

antiOx↑, 1,   Catalase↑, 1,   GPx↑, 1,   GSH↑, 1,   HDL↑, 1,   HO-1↓, 1,   Keap1↓, 1,   MDA↓, 1,   NRF2↑, 1,   ROS↓, 1,   ROS↑, 2,   ROS∅, 1,   SOD↑, 1,   SOD1↑, 1,  

Core Metabolism/Glycolysis

FABP4↓, 1,   glucose↝, 1,   GLUT2↑, 1,   HMG-CoA↓, 1,   PPARγ↓, 1,  

Cell Death

Akt↑, 1,   Casp3↓, 1,   Casp9↓, 1,   Fas↓, 1,   HGF/c-Met↑, 1,   iNOS↓, 1,   JNK↑, 1,   p‑JNK↑, 3,   MAPK↓, 1,  

Kinase & Signal Transduction

OCN∅, 1,  

Transcription & Epigenetics

other↑, 1,  

Protein Folding & ER Stress

CHOP↑, 2,   cl‑eIF2α↑, 1,   GRP78/BiP↑, 2,   GRP94↑, 1,   p‑PERK↑, 1,  

Proliferation, Differentiation & Cell State

Diff↓, 1,   p‑ERK↑, 2,   mTOR↑, 1,   p‑P70S6K↑, 1,   PI3K↑, 1,   RUNX2∅, 1,   Wnt↑, 1,  

Migration

COL1∅, 1,  

Immune & Inflammatory Signaling

COX2↓, 1,   IL1β↓, 1,   Inflam↓, 1,   NF-kB↓, 1,   TLR4↓, 2,   TNF-α↓, 1,  

Protein Aggregation

AGEs↓, 1,  

Drug Metabolism & Resistance

BioAv↑, 1,   BioAv↝, 1,  

Clinical Biomarkers

ALP∅, 1,  

Functional Outcomes

hepatoP↑, 1,   neuroP↑, 1,   RenoP↑, 1,   toxicity↓, 3,   toxicity↝, 1,  

Infection & Microbiome

AntiViral↑, 1,  
Total Targets: 59

Scientific Paper Hit Count for: JNK, c-Jun N-terminal kinase (JNK)
2 Magnetic Fields
1 Silver-NanoParticles
1 Vitamin C (Ascorbic Acid)
1 Alpha-Lipoic-Acid
1 Carvacrol
1 Chlorogenic acid
1 Chrysin
1 Gambogic Acid
1 Magnetic Field Rotating
1 Propolis -bee glue
1 SonoDynamic Therapy UltraSound
1 Hyperthermia
1 Plumbagin
1 Vitamin K2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:49  Cells:%  prod#:%  Target#:168  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page